Gnomegen is a biotechnology company focused on developing instruments, consumables, and reagents for cancer diagnostic purposes. The goal of the products are to meet unmet needs in liquid biopsy. Gnomegen's vision is to help cancer patients live longer and better with innovative liquid biopsy tools for early detection of relapse and progression of cancer.